Physician profile
Asher Goldstein
NPI 1790725661
$8,130.73
in general payments reported to CMS, 2019-2025
30 companies · $3,232 in 2025
The $3,232 reported for 2025 was more than what 91% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $98.76 · 2021: $922 · 2022: $118 · 2023: $2,801 · 2024: $334 · 2025: $3,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,853 · Travel and Lodging: $2,488 · Education: $26.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,852.66 |
| Travel and Lodging | $2,487.96 |
| Education | $26.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $3,105.25 | 2021-2023 | Intracept |
| Saluda Medical Americas, INC. | $2,383.09 | 2023-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $450.67 | 2019-2021 | |
| Curonix LLC | $242.58 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $228.31 | 2019-2025 | Sprint Pns System |
| Mml US, INC. | $227.69 | 2023 | Reactiv8 |
| Spinal Simplicity, LLC | $202.18 | 2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $183.37 | 2019-2025 | Intracept Rf Probe, Intracept |
| Nalu Medical, INC. | $176.59 | 2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $171.59 | 2022-2025 | O-Arm |
| Foundation Fusion Solutions, LLC | $124.91 | 2024 | |
| Medtronic USA, INC. | $112.27 | 2019 | |
| Globus Medical, INC. | $104.45 | 2025 | Senza |
| Bioventus LLC | $81.01 | 2021 | |
| Grt US Holding, INC. | $42.00 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $33.01 | 2020 | |
| Vertos Medical, INC. | $32.72 | 2022-2024 | Mild Device Kit |
| Ibsa Pharma INC. | $26.94 | 2021 | |
| Biodelivery Sciences International, INC. | $26.56 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $25.46 | 2019 | |
| Collegium Pharmaceutical, INC. | $23.36 | 2020-2021 | |
| Biotronik Nro, INC. | $18.08 | 2025 | Prospera |
| Protega Pharmaceutials INC | $16.04 | 2025 | Roxybond |
| Nevro Corp. | $15.51 | 2024 | Senza |
| Daiichi Sankyo INC. | $13.81 | 2019 | |
| Zyla Life Sciences, INC. | $13.43 | 2019 | |
| Glaxosmithkline, LLC. | $13.25 | 2020 | |
| Assertio Therapeutics, INC. | $12.42 | 2019 | |
| Virtus Pharmaceuticals LLC | $12.10 | 2021 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asher Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.